In conclusion, our findings provide initial evidence that certain SNPs in ANGPT2/TEK and VEGF/VEGFR2 ligand–receptor systems and their combinations may have predictive and prognostic potential in HNSCC, especially in patients receiving radiochemotherapy. This evidence concerns the gene TEK and head and neck squamous cell carcinoma.